InvestorsHub Logo
Followers 13
Posts 4354
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Wednesday, 05/26/2021 7:00:39 PM

Wednesday, May 26, 2021 7:00:39 PM

Post# of 64411
Nutra Pharma is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis. $NPHC